MelvinRMooreMD

PubMed

• 4 citations
  Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.
  Agreen Hadadi, Katherine Er Smith, Limeng Wan, Jacqueline R Brown, Greta Russler, Lauren Yantorni, Sarah Caulfield, Jennifer Lafollette, Melvin Moore, Omer Kucuk, Brad...> ;Urologic Oncology. 2022 Jun 1
• 9 citations
  Clinical Outcomes and Racial Disparities in Metastatic Hormone-Sensitive Prostate Cancer in the Era of Novel Treatment Options.
  Katherine Emilie Rhoades Smith, Jacqueline T. Brown, Limeng Wan, Yuan Liu, Greta Russler, Lauren Yantorni, Sarah Caulfield, Jennifer Ann LaFollette, Melvin R. Moore, O...> ;The Oncologist. 2021 Jun 29
• Clinical Characteristics and Outcomes of Late Relapse in Stage I Testicular Seminoma.
  Hosni A, Warde P, Jewett M, Bedard P, Hamilton R, Moore M, Nayan M, Huang R, Atenafu EG, O'Malley M, Sweet J, Chung P> ;Clin Oncol (R Coll Radiol). 2016-10-01
• A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital.
  Chin SN, Wang L, Moore M, Sridhar SS> ;Curr Oncol. 2010-04-01
• A review of the patterns of docetaxel use for hormone refractory prostate cancer (HRPC) at the Princess Margaret Hospital.
  Chin SN, Wang L, Lau A, Moore M, Sridhar SS> ;J. Clin. Oncol.. 2009-05-20
• Randomized phase II trial of capecitabine versus capecitabine, low molecular weight heparin, and prednisone in refractory colorectal carcinoma.
  Mak E, Townsley C, Buckman R, Chen E, Lopez L, Wang L, Moore M, Oza AM> ;J. Clin. Oncol.. 2009-05-20
• 59 citations
  A phase II study of the safety and efficacy of the multidrug resistance inhibitor VX-710 combined with doxorubicin and vincristine in patients with recurrent small cel...
  Leena Gandhi, Matthew W. Harding, Marcus Neubauer, Corey J. Langer, Melvin R. Moore, Helen J. Ross, Bruce E. Johnson, Thomas J. Lynch> ;Cancer. 2007 Mar 1
• A phase I study of axitinib (AG-013736), a potent inhibitor of VEGFRs, in combination with gemcitabine (GEM) in patients (pts) with advanced pancreatic cancer.
  Spano J, Moore M, Kim S, Liau KF, Hee B, Bycott P, Boissaye P, Francis S, Peters D, Rixe O> ;J. Clin. Oncol.. 2006-06-20
• Phase II study of bortezomib in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital [PMH] Phase II Consortium.
  Sridhar SS, Stadler W, Le L, Hedley D, Pond G, Wright J, Vokes E, Thomas S, Moore M> ;J. Clin. Oncol.. 2005-06-01
• Should surveillance be considered the standard of care in stage I seminoma?
  Warde PR, Chung P, Sturgeon J, Panzarella T, Giuliani M, Tew-George B, Jewett M, Bayley A, Moore M, Catton C, Gospodarowicz M> ;J. Clin. Oncol.. 2005-06-01
• 52 citations
  The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
  Nicholas J. Robert, Charles L. Vogel, I. Craig Henderson, Joseph A. Sparano, Melvin R. Moore, Paula Silverman, Beth Overmoyer, Charles L. Shapiro, John W. Park, Gail T...> ;Seminars in Oncology. 2004 Dec 1
• 226 citations
  Phase III Comparison of Two Irinotecan Dosing Regimens in Second-Line Therapy of Metastatic Colorectal Cancer
  Charles S. Fuchs, Melvin R. Moore, Graydon Harker, Luis Villa, David Rinaldi, J. Randolph Hecht> ;Journal of Clinical Oncology. 2003 Mar 1
• Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients...
  Holmes FA, O'Shaughnessy JA, Vukelja S, Jones SE, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, Liang BC> ;J. Clin. Oncol.. 2002-02-01
• 17 citations
  A Phase II trial of cisplatin plus WR-2721 (amifostine) for metastatic breast carcinoma: an Eastern Cooperative Oncology Group Study (E8188).
  William J. Gradishar, Patricia Stephenson, Donna Glover, Donna Neuberg, Melvin R. Moore, Harold E. Windschitl, Ira Piel, Martin D. Abeloff> ;Cancer. 2001 Nov 15
• 126 citations
  A pilot study of the anti-CD20 monoclonal antibody rituximab in patients with refractory immune thrombocytopenia.
  Mansoor N. Saleh, John Gutheil, Melvin R. Moore, Patty W. Bunch, June Butler, Lori A. Kunkel, Antonio J. Grillo-Lopez, Albert F. LoBuglio> ;Seminars in Oncology. 2000 Dec 1
• 1073 citations
  Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containi...
  Frank V. Fossella, Russell F. DeVore, Ronald N. Kerr, Jeffrey Crawford, Ronald R. Natale, Frank Dunphy, L A Kalman, Vincent A. Miller, Jin Soo Lee, Melvin Moore, David...> ;Journal of Clinical Oncology. 2000 Jun 12
• Progression detection of stage I nonseminomatous testis cancer on surveillance: implications for the followup protocol.
  Sharir S, Jewett MA, Sturgeon JF, Moore M, Warde PR, Catton CN, Gospodarowicz MK> ;J. Urol.. 1999-02-01
• 30 citations
  The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
  Winston C. V. Parris, Benjamin W. Johnson, Marilyn K. Croghan, Melvin R. Moore, Ali Khojasteh, Robert F. Reder, Robert Francis Kaiko, Barbara J. Buckley> ;Journal of Pain and Symptom Management. 1998 Oct 1
• Management of stage II seminoma.
  Warde P, Gospodarowicz M, Panzarella T, Catton C, Sturgeon J, Moore M, Jewett M> ;J. Clin. Oncol.. 1998-01-01
• Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
  Warde P, Gospodarowicz MK, Panzarella T, Catton CN, Sturgeon JF, Moore M, Goodman P, Jewett MA> ;J. Clin. Oncol.. 1995-09-01
• Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.
  Crown J, Kritz A, Vahdat L, Reich L, Moore M, Hamilton N, Schneider J, Harrison M, Gilewski T, Hudis C> ;J. Clin. Oncol.. 1993-06-01
• Rapid delivery of multiple high-dose chemotherapy courses with granulocyte colony-stimulating factor and peripheral blood-derived hematopoietic progenitor cells.
  Crown J, Wassherheit C, Hakes T, Fennelly D, Reich L, Moore M, Schneider J, Curtin J, Rubin SC, Reichman B> ;J. Natl. Cancer Inst.. 1992-12-16
• 76 citations
  Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trial
  Enrique Velez-Garcia, John T. Carpenter, Melvin R. Moore, Charles L. Vogel, Victor A. Marcial, Alfred Ketcham, Karan P. Singh, David Bass, Alfred A. Bartolucci, Richar...> ;European Journal of Cancer. 1992 Jan 1
• 14 citations
  A survey of alcohol use in an inner-city ambulatory care setting.
  David G. Simon, J. William Eley, Raymond S. Greenberg, Nancy Newman, Theresa W. Gillespie, Melvin R. Moore> ;Journal of General Internal Medicine. 1991 Jul 1
• How American oncologists treat breast cancer: an assessment of the influence of clinical trials.
  Belanger D, Moore M, Tannock I> ;J. Clin. Oncol.. 1991-01-01
• Join now to see all